Atlas Trials

Phase 1

65,473 clinical trials · Phase

Sort:Newest firstOldest first

◉ Watch Phase 1

RecordFirmDate
Safety, Pharmacokinetic and Pharmacodynamic Study of COR-1, an Anti-ß1 Receptor Antibody Cyclopeptide (NCT01043146)Corimmun GmbH2009-10-01
Everolimus, Carboplatin, and Paclitaxel in Locally Advanced Head and Neck Cancer That Cannot Be Removed by Surgery (NCT01333085)GERCOR - Multidisciplinary Oncology Cooperative Group2009-10-01
Trial for Studying Pharmacokinetic Effects of Ketoconazole on CG100649 (NCT01154764)CrystalGenomics, Inc.2009-10-01
Safety Study of Dantrolene in Subarachnoid Hemorrhage (NCT01024972)University of Massachusetts, Worcester2009-10-01
A Safety, Tolerability and Pharmacokinetic Study of LEO 29102 in Subjects With Atopic Dermatitis (NCT01005823)LEO Pharma2009-10-01
A Bioequivalence Study Of 80 Mg Atorvastatin Calcium Tablets Versus 80 Mg Lipitor® Tablets Under Fed Conditions (NCT01499771)Ranbaxy Laboratories Limited2009-10-01
Lenalidomide and Gemcitabine as First-line Treatment in Patients With Pancreatic Cancer (NCT01547260)Maria Liljefors2009-10-01
A Study In Healthy Volunteers To Estimate The Pharmacokinetics Of Four Modified-Release Formulations Of Dimebon (Latrepirdine) (NCT00988624)Pfizer2009-10-01
Safety of Lactobacillus Reuteri (L. Reuteri) in Healthy Adults (NCT00922727)The University of Texas Health Science Center, Houston2009-10-01
Effect of the Kv7-channel Opener Flupirtine on the Excitability of Human Peripheral Myelinated Axons in Vivo (NCT01450865)Ludwig-Maximilians - University of Munich2009-10-01
Effect of Remote Ischemic Preconditioning on Cognitive Function After Off-Pump Coronary Artery Bypass Graft (NCT00953368)Asan Medical Center2009-10-01
The Effect of Food (High Fat and Low Fat Breakfast) on the Pharmacokinetics of Regorafenib (NCT01002378)Bayer2009-10-01
Margin-Intense Combo Therapy in Pts w/Potentially Resectable Pancreatic Cancer (NCT01025882)University of Texas Southwestern Medical Center2009-10-01
Dose Escalation Study of NKP-1339 to Treat Advanced Solid Tumors (NCT01415297)Niiki Pharma Inc.2009-10-01
Hepatocellular Carcinoma (HCC)_Torisel_ (NCT01251458)Chinese University of Hong Kong2009-10-01
Study of Perifosine + Capecitabine for Colon Cancer Patients (NCT01048580)AEterna Zentaris2009-10-01
Pharmacokinetics and Safety of Piperacillin-tazobactam in Neonates (NCT00873327)Phillip Brian Smith2009-10-01
Phase I Oncovir Poly IC:LC and NY-ESO-1/gp100 (NCT01008527)H. Lee Moffitt Cancer Center and Research Institute2009-10-01
A Study to Investigate Safety, Tolerability and Pharmacokinetics of AZD1446 Administered for 4 Weeks in Elderly Healthy Volunteers (NCT00997308)AstraZeneca2009-10-01
Safety, Pharmacokinetics and Pharmacodynamics Study of Treatment With CHF 5074 in Healthy Young Male Subjects (NCT00954252)CERESPIR2009-10-01
Dendritic Cell Vaccine With Imiquimod for Patients With Malignant Glioma (NCT01792505)Cedars-Sinai Medical Center2009-10-01
A Safety and Tolerability Study of Clofarabine, Etoposide, Cyclophosphamide, PEG-asparaginase, and Vincristine in Pediatric Acute Lymphoblastic Leukemia (ALL) (NCT00991133)Genzyme, a Sanofi Company2009-10-01
Bioequivalence Study of Ropinirole Hydrochloride ER Tablets 2 mg Under Fasting Condition (NCT01627834)Dr. Reddy's Laboratories Limited2009-10-01
Study of TAK-901 in Adults With Advanced Solid Tumors or Lymphoma (NCT00935844)Millennium Pharmaceuticals, Inc.2009-10-01
10mg ZD4054 (Zibotentan) PK Study in Male, Elderly Chinese Patients With Advanced Solid Malignancies (NCT00997945)AstraZeneca2009-10-01
Pilot Study of Electronic Uterine Contraction Inhibitor (NCT00994058)Winthrop University Hospital2009-10-01
Mesenchymal Stem Cells Treat Liver Cirrhosis (NCT01233102)Yufang Shi2009-10-01
Comparison of the Effect of NN5401 With the Effect of NN1250 and Insulin Aspart in Type 1 Diabetics (NCT00992537)Novo Nordisk A/S2009-10-01
Surgical Bleeding Control of Extra-corporeal Circulation (ECC) by Vacuum Devices (NCT00843596)AdministrateurCIC2009-10-01
The Shang Ring: A Novel Male Circumcision Device for HIV Prevention (NCT00993811)Weill Medical College of Cornell University2009-10-01
Tamibarotene and Arsenic Trioxide for Relapsed Acute Promyelocytic Leukemia (NCT00985530)Northwestern University2009-10-01
Immunoadsorption in Patients With Pulmonary Hypertension (NCT01126411)University Medicine Greifswald2009-10-01
Assess the Safety, Tolerability, and Pharmacokinetic (PK) Characteristics of HM10460A (HNK460) in Healthy Adult Korean Subjects (NCT00998283)Hanmi Pharmaceutical Company Limited2009-10-01
Study Evaluating the Tolerance and Biologic Activity of Oral Ciclopirox Olamine in Patients With Relapsed or Refractory Hematologic Malignancy (NCT00990587)University Health Network, Toronto2009-10-01
Comparison of Hypoglycaemic Response Between NN1250 and Insulin Glargine in Type 1 Diabetics (NCT01002768)Novo Nordisk A/S2009-10-01
The COMparison of CALcium Bioavailability Between AlgaeCal® and a Proprietary Supplement (NCT01609413)Sprim Italia2009-10-01
Relative Bioavailability, Transdermally Administered EE and GSD, 3 Applications Sites (NCT01083264)Bayer2009-10-01
Intrahepatic Reinfusion of CD133+ Stem Cells in Cirrhotic Patients (NCT01025622)University of Bologna2009-10-01
A Study of BKM120 in Adult Japanese Patients With Advanced Solid Tumors (NCT01283503)Novartis Pharmaceuticals2009-10-01
Safety of BB-12 Supplemented Strawberry Yogurt For Healthy Adults on Antibiotics (NCT00848003)Georgetown University2009-10-01
A Study Evaluating ABT-263 With Erlotinib, ABT-263 With Irinotecan, and ABT-263 Monotherapy in Cancer Subjects (NCT01009073)AbbVie (prior sponsor, Abbott)2009-10-01
Trial on the Safety of a New Liposomal Adjuvant System, CAF01, When Given With the Tuberculosis Subunit Vaccine Ag85B-ESAT-6 as Two Injections With Two Months Interval to Healthy Adult Volunteers (NCT00922363)Statens Serum Institut2009-10-01
Veliparib With or Without Mitomycin C in Treating Patients With Metastatic, Unresectable, or Recurrent Solid Tumors (NCT01017640)National Cancer Institute (NCI)2009-10-01
Erlotinib Hydrochloride in Preventing Cancer in Patients With Precancerous Lesions of the Lung (NCT01013831)National Cancer Institute (NCI)2009-10-01
Phase I/II Study of Irinotecan and Temsirolimus in Patients With Refractory Sarcomas (NCT00996346)New Mexico Cancer Research Alliance2009-10-01
Evaluation of the Neuroinflammation Pattern of BAY85-8102 F-18, DPA-714 in Probable Alzheimers Disease Patients Versus Healthy Volunteers and Radiation Dosimetry of F 18, DPA-714 in Healthy Volunteers (NCT01009359)Bayer2009-10-01
Safety and Tolerability Study of the Taris Placebo System (NCT01051336)TARIS Biomedical, Inc.2009-10-01
A Study to Assess PV-10 Chemoablation of Cancer of the Liver (NCT00986661)Provectus Biopharmaceuticals, Inc.2009-10-01
Zinc Absorption From Zinc Biofortified Rice (NCT01346722)International Centre for Diarrhoeal Disease Research, Bangladesh2009-10-01
Intra-arterial Measurement of pO2 in Walking Induced Transient Hack Profiles (NCT01022606)University Hospital, Angers2009-10-01
A Phase 1 Single-Dose Escalation Study of PF-04308515 in Healthy Volunteers (NCT00990015)Pfizer2009-10-01
Multiple Dose Study In Treatment Naive Subjects Infected With Hepatitis C Virus (NCT00971308)Bristol-Myers Squibb2009-10-01
A Study to Characterize Event Related Potential Markers of Attentional Bias Towards Words and Images of Food (NCT01366508)GlaxoSmithKline2009-10-01
A Study of the Safety and Pharmacokinetics of AGS-8M4 Given in Combination With Chemotherapy in Women With Ovarian Cancer (NCT01016054)Astellas Pharma Inc2009-10-01
Phase 1 Trial of Type II Collagen (CII) APL A12 in Rheumatoid Arthritis Patients (NCT01123655)VA Office of Research and Development2009-10-01
Study to Investigate Safety, Tolerability and Pharmacokinetics of AZD2423 Multiple Doses in Healthy Volunteers (NCT00977626)AstraZeneca2009-10-01
EMD 525797 in Combination With Cetuximab and Irinotecan in K-ras Wild Type Metastatic Colorectal Cancer (NCT01008475)Merck KGaA, Darmstadt, Germany2009-10-01
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of BI 653048 BS H3PO4 Capsule Multiple Rising Doses in Healthy Male Volunteers (NCT02217631)Boehringer Ingelheim2009-10-01
Assess the Oral Bioavailability of a New ABT-263 Formulation in Subjects With Cancer (NCT00982566)AbbVie2009-10-01
A Study of ABT-384 Levels and Pharmacodynamic Activity Measured in Cerebrospinal Fluid (NCT01009216)Abbott2009-10-01
ARMOR1: Study of TOK-001 to Treat Castration Resistant Prostate Cancer (NCT00959959)LTN PHARMACEUTICALS, INC.2009-10-01
Evaluate a Medication on How Hunger and Appetite Are Influenced by Smell (NCT01021176)Pennington Biomedical Research Center2009-10-01
Phase I Dose Escalation Study of Concomitant BIBF 1120 and BIBW 2992 in Patients With Advanced Solid Tumours. (NCT00998296)Boehringer Ingelheim2009-10-01
Dendritic Cell-based Immunotherapy Combined With Low-dose Cyclophosphamide in Patients With Malignant Mesothelioma (NCT01241682)Erasmus Medical Center2009-10-01
The Effects of Whole Food Intervention on Mucositis in Patients Treated for Head and Neck Cancer (NCT02575313)Providence Health & Services2009-10-01
The Effectiveness of a Pediatric Lumbar Puncture Restraint Device (NCT00980070)University of Nebraska2009-10-01
Escalating Dose Study in Healthy Volunteers With SEN0014196 (NCT01521832)Siena Biotech S.p.A.2009-10-01
Comparison of Hookah and Cigarette Smoking (NCT00992550)University of California, San Francisco2009-10-01
Study of Serum Testosterone Levels in Non-dosed Females After Secondary Exposure (NCT00998933)Solvay Pharmaceuticals2009-10-01
Study to Assess the Effect of BMS-790052 on the Pharmacokinetics of Ortho Tri-Cyclen® in Healthy Female Subjects (NCT00983957)Bristol-Myers Squibb2009-10-01
A Study To Explore The Effect On Inflammatory Markers After Nasal Allergen Challenge In Subjects With Seasonal Allergic Rhinitis And The Effect Of A Single Dose Of Ibuprofen Or Fluticasone Propionate On The Allergen Response. (NCT01064726)Pfizer2009-10-01
Peanut Allergy Vaccine Study in Healthy and Peanut-allergic Adults (NCT00850668)Allertein Therapeutics, LLC2009-10-01
The Effect of Ketamine on Attentiveness (NCT01165294)Johnson & Johnson Pharmaceutical Research & Development, L.L.C.2009-10-01
Cocoa Flavanols and Painfree Walking Distance (NCT01064583)Heinrich-Heine University, Duesseldorf2009-10-01
Treatment of Patients With Trophic Ulcers Using Mesenchymal Stem Cells (NCT04457037)Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus2009-10-01
Combination Study of BMS-754807 and Erbitux® in Subjects With Advanced or Metastatic Solid Tumors (NCT00908024)Bristol-Myers Squibb2009-10-01
Safety and Tolerability Study of the Monoclonal Antibody CT-011 in Patients With Hepatocellular Carcinoma (NCT00966251)CureTech Ltd2009-10-01
A Randomized, Double-Blind, Placebo-Controlled Multiple Dose Trial of GS-9411 in Healthy Volunteers (NCT00999531)Gilead Sciences2009-10-01
A Pilot Study of Pre-Exposure Prophylaxis (PrEP) to Evaluate Safety, Acceptability, and Adherence in At-Risk Populations in Kenya, Africa (NCT00971230)International AIDS Vaccine Initiative2009-10-01
Safety, Tolerability, Pharmacokinetics And Measurement Of Whole Blood Activity (WBA) Of PNU-100480 After Multiple Oral Doses In Healthy Adult Volunteers (NCT00990990)Sequella, Inc.2009-10-01
A Trial to Assess the Effect of Liraglutide on Blood Triglyceride (Fat) Levels After a Meal in Type 2 Diabetics (NCT00993304)Novo Nordisk A/S2009-10-01
Capecitabine, Vorinostat, and Radiation Therapy in Treating Patients With Nonmetastatic Pancreatic Cancer (NCT00983268)Vanderbilt-Ingram Cancer Center2009-10-01
A Study Evaluating The Absorption Of Dimebon Into The Body From A Dimebon Solution Applied To The Skin (NCT00990613)Pfizer2009-10-01
Bio Equivalence Study of Torrent Pharmaceutical Ltd's Rosuvastatin Calcium Tablets Under Fasting Condition. (NCT02962310)Torrent Pharmaceuticals Limited2009-10-01
Bioequivalence Study of Donepezil Hydrochloride 10 mg Tablets Under Fasting Conditions (NCT01276067)Ranbaxy Laboratories Limited2009-10-01
Study Assessing Safety and Tolerability of AZD8931 Alone or in Combination With Paclitaxel in Japanese Patients. (NCT01003158)AstraZeneca2009-10-01
Bioequivalence Study for Donepezil Hydrochloride 10 mg Tablets Under Fasting Condition (NCT01504503)Dr. Reddy's Laboratories Limited2009-10-01
Study to Evaluate ATP-induced Pain and ATP-induced Dermal Vasodilation by Iontophoresis (0000-118)(COMPLETED) (NCT00917696)Merck Sharp & Dohme LLC2009-10-01
Safety Study of PLX108-01 in Patients With Solid Tumors (NCT01004861)Daiichi Sankyo2009-10-01
Treated T Cells Followed by a Stem Cell Transplant in Treating Patients With Multiple Myeloma (NCT00938626)Barbara Ann Karmanos Cancer Institute2009-10-01
NOX-A12 First-in-human (FIH) Study (NCT00976378)TME Pharma AG2009-10-01
Cognitive Behavioral Therapy Delivered Over the Internet for Women With Postpartum Depression (NCT00942721)Oregon Research Institute2009-10-01
The Effects of Whole Food Intervention on Mucositis in Patients Treated for Thoracic Cancer (NCT02575391)Providence Health & Services2009-10-01
A Functional Food for the Prevention of Iron-deficiency Anemia (NCT01055431)Manchester Metropolitan University2009-10-01
Administration of Methylprednisolone for Prevention of Ovarian Hyper Stimulation Syndrome (NCT01014104)Royan Institute2009-10-01
A Study of the Safety, Tolerability, Pharmacokinetics, and Bioavailability of IV and SC MABT5102A in Healthy Volunteers (NCT00997919)Genentech, Inc.2009-10-01
Study of Epicutaneously Applied Ketoprofen Transfersome® Gel With or Without Combination With Oral Celecoxib for the Treatment of Muscle Pain Induced by Eccentric Exercise (NCT01020279)X-pert Med GmbH2009-10-01
A Trial of RAD001/Capecitabine in Refractory Gastric Cancer (NCT01099527)Samsung Medical Center2009-10-01
MOD-4023 Study in Healthy Male Volunteers (NCT01060722)OPKO Health, Inc.2009-10-01
Study to Evaluate Safety, Tolerability and Pharmacokinetics of Increasing Repeated Oral Doses of Ambroxol Lozenges in Healthy Male Volunteers (NCT02194283)Boehringer Ingelheim2009-10-01
← Previous Next →

Track Phase 1 automatically

Every clearance here is in the API, with alerts when new ones post.